Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors) Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors)

Enhanced Susceptibility to Oxidation and Diminished Vitamin E Content of LDL from Patients with Stable Coronary Artery Disease (Lipids, Lipoproteins, And Cardiovascular Risk Factors‪)‬

Clinical Chemistry 2001, July, 47, 7

    • $5.99
    • $5.99

Publisher Description

In vitro and animal model studies provide an ever-increasing body of evidence that oxidation of LDL or related oxidative mechanisms play a major role in atherogenesis (1). Oxidative modification of LDL confers several properties to LDL that render the particle atherogenic. Oxidized LDL induces the transformation of macrophages into foam cells; in addition, it is cytotoxic and immunogenic and may have vasoconstrictor and prothrombotic effects (2, 3). The evaluation of LDL oxidation in vivo is difficult. One of the main problems is that LDL oxidation is likely to occur in the intima of the artery wall rather than in the general circulation (4). Even if some lipoproteins are oxidized in the circulation, the concentrations of these modified lipoproteins may be difficult to detect and may not reflect the extent of oxidation occurring in the arterial wall. Thus, susceptibility of LDL to in vitro oxidation has been proposed as an indicator of the response of LDL to in vivo oxidative stress. Much information relating to oxidized LDL has been acquired from studies focusing on various animals. However, the role of LDL susceptibility to oxidation as a risk factor for coronary artery disease (CAD)[5] in humans has not been fully explored. Divergent information is available in this field, which may be explained in part by the use by investigators of small sample sizes (5-8) or nonspecific methods for evaluation of susceptibility of LDL to oxidation (9). Quantitatively, vitamin E is the major antioxidant in LDL and is generally considered to protect LDL against oxidation (10). However, conflicting results were also reported concerning the role of vitamin E in atherosclerosis (11). Recently, one interventional study showed a null effect of vitamin E on atherosclerosis (12). Moreover, a recent in vitro study has shown that vitamin E can be prooxidative rather than protective for lipids in isolated LDL (13).

GENRE
Science & Nature
RELEASED
2001
1 July
LANGUAGE
EN
English
LENGTH
22
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
233.3
KB
Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology) Lowering Cutoffs for Initial and Confirmation Testing for Cocaine and Marijuana: Large-Scale Study of Effects on the Rates of Drug-Positive Results (Drug Monitoring and Toxicology)
1997
Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial) Myocardial Infarction Redefined: Role of Cardiac Troponin Testing (Editorial)
2001
Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry) Distribution of Fasting Plasma Insulin, Free Fatty Acids, And Glucose Concentrations and of Homeostasis Model Assessment of Insulin Resistance in a Representative Sample of Quebec Children and Adolescents (Pediatric Clinical Chemistry)
2003
C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics) C677T and AI298C Polymorphisms of the Methylenetetrahydrofolate Reductase Gene: Incidence and Effect of Combined Genotypes on Plasma Fasting and Post-Methionine Load Homocysteine in Vascular Disease (Molecular Diagnostics and Genetics)
2001
Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs) Acetylcholinesterase Activity and Biogenic Amines in Phenylketonuria (Technical Briefs)
2002
Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report) Homocysteine, 5, 10-Methylenetetrahydrofolate Reductase 677CT Polymorphism, Nutrient Intake, And Incident Cardiovascular Disease in 24 968 Initially Healthy Women (Molecular Diagnostics and Genetics) (Clinical Report)
2007